IntroductionRadial access is the standard of care for nearly all cardiac catheterization procedures. It improves patient satisfaction, reduces the length of stay, and is associated with fewer complications. However, few devices and tools are available for the treatment of peripheral arterial disease via a transradial approach (TRA). The S.M.A.R.T. RADIANZ Vascular Stent System is among the RADIANZ suite of products, which is aimed at expanding the portfolio of devices to treat peripheral arterial disease.Areas CoveredIn this Expert review, the following areas will be covered: (1) Current Landscape of peripheral vascular intervention (PVI) using TRA (2) Detailed description of the S.M.A.R.T. RADIANZ Vascular Stent System. (3) Ongoing clinical trials to evaluate safety of this approach. (4) Future directions and current regulatory status.Expert OpinionTRA for PVI is a promising approach. It holds the possibility of substantially improving the care of patients with peripheral arterial disease (PAD). Numerous challenges must be overcome to realize the full potential of a radial-to-peripheral (RTP) approach. The length of devices and the small sheath size are the main constraints of this approach. The results of the ongoing RADIANCY trial will demonstrate the safety, in selected patients, of the RADIANZ suite of products.
Radial access for peripheral vascular intervention: the S.M.A.R.T. RADIANZ Vascular Stent System / Subramanian, V.; Sauguet, A.; Werner, M.; Sbarzaglia, P.; Hausegger, K. A.; Goyault, G.; Guerra, M.; Deloose, K.; Kahlberg, A.; Balestriero, G.; Brodmann, M.; Binkert, C.; Goueffic, Y.; Groezinger, G.; Schwindt, A.; Schlager, O.; Bertoglio, L.; Adams, G.; Sultana, N.; Coscas, R.. - In: EXPERT REVIEW OF MEDICAL DEVICES. - ISSN 1743-4440. - (2023), pp. 1-6. [10.1080/17434440.2023.2240227]
Radial access for peripheral vascular intervention: the S.M.A.R.T. RADIANZ Vascular Stent System
Kahlberg A.;Bertoglio L.;
2023-01-01
Abstract
IntroductionRadial access is the standard of care for nearly all cardiac catheterization procedures. It improves patient satisfaction, reduces the length of stay, and is associated with fewer complications. However, few devices and tools are available for the treatment of peripheral arterial disease via a transradial approach (TRA). The S.M.A.R.T. RADIANZ Vascular Stent System is among the RADIANZ suite of products, which is aimed at expanding the portfolio of devices to treat peripheral arterial disease.Areas CoveredIn this Expert review, the following areas will be covered: (1) Current Landscape of peripheral vascular intervention (PVI) using TRA (2) Detailed description of the S.M.A.R.T. RADIANZ Vascular Stent System. (3) Ongoing clinical trials to evaluate safety of this approach. (4) Future directions and current regulatory status.Expert OpinionTRA for PVI is a promising approach. It holds the possibility of substantially improving the care of patients with peripheral arterial disease (PAD). Numerous challenges must be overcome to realize the full potential of a radial-to-peripheral (RTP) approach. The length of devices and the small sheath size are the main constraints of this approach. The results of the ongoing RADIANCY trial will demonstrate the safety, in selected patients, of the RADIANZ suite of products.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
